MariMed Inc.
MRMD
$0.1066
$0.00414.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 40.59M | 40.44M | 37.93M | 38.90M | 38.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.59M | 40.44M | 37.93M | 38.90M | 38.80M |
| Cost of Revenue | 23.81M | 23.53M | 21.46M | 21.58M | 21.96M |
| Gross Profit | 16.78M | 16.91M | 16.47M | 17.32M | 16.84M |
| SG&A Expenses | 15.07M | 15.60M | 14.37M | 14.86M | 13.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.88M | 39.13M | 35.83M | 36.44M | 35.48M |
| Operating Income | 1.71M | 1.31M | 2.11M | 2.46M | 3.32M |
| Income Before Tax | -340.00K | -773.00K | 398.00K | -9.63M | 193.00K |
| Income Tax Expenses | 655.00K | 866.00K | 1.69M | 509.00K | 4.46M |
| Earnings from Continuing Operations | -995.00K | -1.64M | -1.29M | -10.14M | -4.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -16.00K | -12.00K | -6.00K | -30.00K | 10.00K |
| Net Income | -1.01M | -1.65M | -1.30M | -10.17M | -4.26M |
| EBIT | 1.71M | 1.31M | 2.11M | 2.46M | 3.32M |
| EBITDA | 4.40M | 4.12M | 4.42M | 5.01M | 5.76M |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.03 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.03 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 380.60M | 379.51M | 375.21M | 376.01M | 373.08M |
| Average Diluted Shares Outstanding | 380.60M | 379.51M | 375.21M | 376.01M | 373.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -11.87% | -- | -- | -- | -3.01% |
